A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors

As survival rates increase, more emphasis has gone to possible cognitive sequelae in older cancer patients, which could be explained by accelerated brain aging. In this review, we provide a complete overview of studies investigating neuroimaging, neurocognitive, and neurodegenerative disorders in ol...

Full description

Bibliographic Details
Main Authors: Charlotte Kerstens, Hans P. M. W. Wildiers, Gwen Schroyen, Mercedes Almela, Ruth E. Mark, Maarten Lambrecht, Sabine Deprez, Charlotte Sleurs
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/4/1215
_version_ 1797621879392960512
author Charlotte Kerstens
Hans P. M. W. Wildiers
Gwen Schroyen
Mercedes Almela
Ruth E. Mark
Maarten Lambrecht
Sabine Deprez
Charlotte Sleurs
author_facet Charlotte Kerstens
Hans P. M. W. Wildiers
Gwen Schroyen
Mercedes Almela
Ruth E. Mark
Maarten Lambrecht
Sabine Deprez
Charlotte Sleurs
author_sort Charlotte Kerstens
collection DOAJ
description As survival rates increase, more emphasis has gone to possible cognitive sequelae in older cancer patients, which could be explained by accelerated brain aging. In this review, we provide a complete overview of studies investigating neuroimaging, neurocognitive, and neurodegenerative disorders in older cancer survivors (>65 years), based on three databases (Pubmed, Web of Science and Medline). Ninety-six studies were included. Evidence was found for functional and structural brain changes (frontal regions, basal ganglia, gray and white matter), compared to healthy controls. Cognitive decline was mainly found in memory functioning. Anti-hormonal treatments were repeatedly associated with cognitive decline (tamoxifen) and sometimes with an increased risk of Alzheimer’s disease (androgen deprivation therapy). Chemotherapy was inconsistently associated with later development of cognitive changes or dementia. Radiotherapy was not associated with cognition in patients with non-central nervous system cancer but can play a role in patients with central nervous system cancer, while neurosurgery seemed to improve their cognition in the short-term. Individual risk factors included cancer subtypes (e.g., brain cancer, hormone-related cancers), treatment (e.g., anti-hormonal therapy, chemotherapy, cranial radiation), genetic predisposition (e.g., APOE, COMT, BDNF), age, comorbidities (e.g., frailty, cognitive reserve), and psychological (e.g., depression, (post-traumatic) distress, sleep, fatigue) and social factors (e.g., loneliness, limited caregiver support, low SES). More research on accelerated aging is required to guide intervention studies.
first_indexed 2024-03-11T09:02:18Z
format Article
id doaj.art-be11dc799bf94fe7963d76b2e8151901
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T09:02:18Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-be11dc799bf94fe7963d76b2e81519012023-11-16T19:37:52ZengMDPI AGCancers2072-66942023-02-01154121510.3390/cancers15041215A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer SurvivorsCharlotte Kerstens0Hans P. M. W. Wildiers1Gwen Schroyen2Mercedes Almela3Ruth E. Mark4Maarten Lambrecht5Sabine Deprez6Charlotte Sleurs7Department of Oncology, University Hospital Ghent, 9000 Ghent, BelgiumLeuven Cancer Institute, KU Leuven, 3000 Leuven, BelgiumLeuven Cancer Institute, KU Leuven, 3000 Leuven, BelgiumDepartment of Cognitive Neuropsychology, Tilburg University, 5030AB Tilburg, The NetherlandsDepartment of Cognitive Neuropsychology, Tilburg University, 5030AB Tilburg, The NetherlandsLeuven Cancer Institute, KU Leuven, 3000 Leuven, BelgiumLeuven Cancer Institute, KU Leuven, 3000 Leuven, BelgiumLeuven Cancer Institute, KU Leuven, 3000 Leuven, BelgiumAs survival rates increase, more emphasis has gone to possible cognitive sequelae in older cancer patients, which could be explained by accelerated brain aging. In this review, we provide a complete overview of studies investigating neuroimaging, neurocognitive, and neurodegenerative disorders in older cancer survivors (>65 years), based on three databases (Pubmed, Web of Science and Medline). Ninety-six studies were included. Evidence was found for functional and structural brain changes (frontal regions, basal ganglia, gray and white matter), compared to healthy controls. Cognitive decline was mainly found in memory functioning. Anti-hormonal treatments were repeatedly associated with cognitive decline (tamoxifen) and sometimes with an increased risk of Alzheimer’s disease (androgen deprivation therapy). Chemotherapy was inconsistently associated with later development of cognitive changes or dementia. Radiotherapy was not associated with cognition in patients with non-central nervous system cancer but can play a role in patients with central nervous system cancer, while neurosurgery seemed to improve their cognition in the short-term. Individual risk factors included cancer subtypes (e.g., brain cancer, hormone-related cancers), treatment (e.g., anti-hormonal therapy, chemotherapy, cranial radiation), genetic predisposition (e.g., APOE, COMT, BDNF), age, comorbidities (e.g., frailty, cognitive reserve), and psychological (e.g., depression, (post-traumatic) distress, sleep, fatigue) and social factors (e.g., loneliness, limited caregiver support, low SES). More research on accelerated aging is required to guide intervention studies.https://www.mdpi.com/2072-6694/15/4/1215neurodegenerationcognitionagingoldercancer survivors
spellingShingle Charlotte Kerstens
Hans P. M. W. Wildiers
Gwen Schroyen
Mercedes Almela
Ruth E. Mark
Maarten Lambrecht
Sabine Deprez
Charlotte Sleurs
A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors
Cancers
neurodegeneration
cognition
aging
older
cancer survivors
title A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors
title_full A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors
title_fullStr A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors
title_full_unstemmed A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors
title_short A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors
title_sort systematic review on the potential acceleration of neurocognitive aging in older cancer survivors
topic neurodegeneration
cognition
aging
older
cancer survivors
url https://www.mdpi.com/2072-6694/15/4/1215
work_keys_str_mv AT charlottekerstens asystematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT hanspmwwildiers asystematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT gwenschroyen asystematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT mercedesalmela asystematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT ruthemark asystematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT maartenlambrecht asystematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT sabinedeprez asystematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT charlottesleurs asystematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT charlottekerstens systematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT hanspmwwildiers systematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT gwenschroyen systematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT mercedesalmela systematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT ruthemark systematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT maartenlambrecht systematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT sabinedeprez systematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors
AT charlottesleurs systematicreviewonthepotentialaccelerationofneurocognitiveaginginoldercancersurvivors